Note

Pfizer Inc.: technical analysis

· Views 12



Pfizer Inc.: technical analysis
Scenario
TimeframeWeekly
RecommendationBUY STOP
Entry Point29.60
Take Profit31.30
Stop Loss29.20
Key Levels26.50, 28.00, 28.30, 29.00, 29.20, 29.60, 30.00, 31.50, 31.70
Alternative scenario
RecommendationSELL STOP
Entry Point28.30
Take Profit26.50
Stop Loss29.00
Key Levels26.50, 28.00, 28.30, 29.00, 29.20, 29.60, 30.00, 31.50, 31.70

Shares of Pfizer Inc., the largest American pharmaceutical company, are correcting at 29.00.

On the daily chart, the price is above the support line of the ascending channel with dynamic boundaries of 31.70–28.00, moving away from it.

On the four-hour chart, the quotes could not leave the range and reversed at the support level of 28.00. After consolidating above 30.00, the asset may reach the annual high of 31.50. However, in the event of a return to the 28.00 area, negative dynamics may develop.

Technical indicators do not provide a stable signal: fast EMAs on the Alligator indicator are above the signal line, and the AO histogram forms correction bars above the transition level.

Pfizer Inc.: technical analysis

Trading tips

Long positions may be opened after the price rises and consolidates above 29.60, with the target at 31.30. Stop loss is 29.20. Implementation period: 7 days or more.

Short positions may be opened after the price falls and consolidates below 28.30, with the target at 26.50. Stop loss is 29.00.


Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.

FOLLOWME Trading Community Website: https://www.followme.com

If you like, reward to support.
avatar

Hot

No comment on record. Start new comment.